There are many things far more evil than Trump. The American medical mafia is one of them. Breast cancer in women can be greatly reduced and the American medical mafia knows this. Trump is a pussy grabbing, child raping, traitor but even he would not withhold something that would reduce the incidences of breast cancer.
The American Medical Mafia makes a fortune on breast cancers and all other preventable cancers.
Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study
Abstract
Objectives: There is evidence that androgens are breast protective and that testosterone therapy treats many symptoms of hormone deficiency in both pre and postmenopausal patients. However, unlike estrogen and progestins, there is a paucity of data regarding the incidence of breast cancer in women treated with testosterone therapy. This study was designed to investigate the incidence of breast cancer in women treated with subcutaneous testosterone therapy in the absence of systemic estrogen therapy.
Study design: This is a 5-year interim analysis of a 10-year, prospective, observational, IRB approved study investigating the incidence of breast cancer in women presenting with symptoms of hormone deficiency treated with subcutaneous testosterone (T) implants or, T combined with the aromatase inhibitor anastrozole (A), i.e., T+A implants. Breast cancer incidence was compared with that of historical controls reported in the literature, age specific Surveillance Epidemiology and End Results (SEER) incidence rates, and a representative, similar age group of our patients used as a 'control' group. The effect of adherence to T therapy was also evaluated.
Results: Since March 2008, 1268 pre and post menopausal women have been enrolled in the study and eligible for analysis. As of March 2013, there have been 8 cases of invasive breast cancer diagnosed in 5642 person-years of follow up for an incidence of 142 cases per 100000 person-years, substantially less than the age-specific SEER incidence rates (293/100000), placebo arm of Women's Health Initiative Study (300/100000), never users of hormone therapy from the Million Women Study (325/100000) and our control group (390/100000). Unlike adherence to estrogen therapy, adherence to T therapy further decreased the incidence of breast cancer (73/100000).
Conclusion: T and/or T+A, delivered subcutaneously as a pellet implant, reduced the incidence of breast cancer in pre and postmenopausal women. Evidence supports that breast cancer is preventable by maintaining a T to estrogen ratio in favor of T and, in particular, by the use of continuous T or, when indicated, T+A. This hormone therapy should be further investigated for the prevention and treatment of breast cancer.
Keywords: Anastrozole; Breast cancer; Implants; Prevention; Testosterone.
Copyright © 2013 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.
Similar articles
- Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study.BMC Cancer. 2019 Dec 30;19(1):1271. doi: 10.1186/s12885-019-6457-8.PMID: 31888528 Free PMC article.
- Testosterone and breast cancer prevention.Maturitas. 2015 Nov;82(3):291-5. doi: 10.1016/j.maturitas.2015.06.002. Epub 2015 Jun 24.PMID: 26160683 Review.
- Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.Arch Intern Med. 2006 Jul 24;166(14):1483-9. doi: 10.1001/archinte.166.14.1483.PMID: 16864758
- Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.Breast Cancer Res Treat. 2007 Nov;106(1):75-84. doi: 10.1007/s10549-006-9476-5. Epub 2007 Jan 13.PMID: 17221152 Clinical Trial.
- Role of anastrozole across the breast cancer continuum: from advanced to early disease and prevention.Oncology. 2006;70(1):1-12. doi: 10.1159/000091180. Epub 2006 Jan 26.PMID: 16439860 Review.
Cited by 11 articles
- Low complication rates of testosterone and estradiol implants for androgen and estrogen replacement therapy in over 1 million procedures.Ther Adv Endocrinol Metab. 2021 May 27;12:20420188211015238. doi: 10.1177/20420188211015238. eCollection 2021.PMID: 34104398 Free PMC article.
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.J Womens Health (Larchmt). 2021 Apr;30(4):474-491. doi: 10.1089/jwh.2021.29037. Epub 2021 Apr 1.PMID: 33797277 Free PMC article.
- Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study.BMC Cancer. 2019 Dec 30;19(1):1271. doi: 10.1186/s12885-019-6457-8.PMID: 31888528 Free PMC article.
- Impaired redox regulation of estrogen metabolizing proteins is important determinant of human breast cancers.Cancer Cell Int. 2019 May 15;19:111. doi: 10.1186/s12935-019-0826-x. eCollection 2019.PMID: 31114446 Free PMC article. Review.
- Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.Clin Breast Cancer. 2019 Feb;19(1):e12-e19. doi: 10.1016/j.clbc.2018.11.007. Epub 2018 Nov 14.PMID: 30527351 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
No comments:
Post a Comment
If you support Trump you deserve cancer.